1. An implantable hearing prosthesis for a recipient patient, the prosthesis comprising:
a receiving coil for transcutaneous receiving of an externally generated communication data signal;
an implantable signal processor in communication with the receiving coil for converting the communication data signal into an electrical stimulation signal;
an implantable transducer housing for fixed attachment to skull bone of the patient, the housing forming a hermetically sealed can containing a fixed permanent magnet arrangement portion of an implantable transducer; and
an implantable electromagnetic drive portion of the implantable transducer in communication with the signal processor and configured to be:
i. connected to and within the implantable transducer housing and engageable with the permanent magnet arrangement portion for applying to the transducer housing a mechanical vibration signal based on the electrical stimulation signal for audio perception by the patient, and
ii. freely removable from the implantable transducer housing to be removed from the implantable transducer housing without detaching the implantable transducer housing from the skull bone.
2. A prosthesis according to claim 1, wherein the transducer housing is adapted for fixed attachment to the skull bone by a pair of radially opposed bone screws.
3. A prosthesis according to claim 1, wherein the transducer housing is adapted for fixed attachment into a recessed housing well in the skull bone.
4. A prosthesis according to claim 1, wherein the can is sealed by a silicone elastomer.
5. A prosthesis according to claim 1, further comprising:
an encapsulation layer of biocompatible material covering the electromagnetic drive portion.
6. A prosthesis according to claim 1, further comprising:
a sealing lens of biocompatible material across an outer axial end of the electromagnetic drive portion.
7. A prosthesis according to claim 1, further comprising:
a coupling spring coupling the electromagnetic drive portion to the transducer housing.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A seed of soybean cultivar 4211676, wherein a representative sample of seed of said cultivar was deposited under ATCC Accession No. PTA-9114.
2. A soybean plant, or a part thereof, produced by growing the seed of claim 1.
3. A tissue culture of cells produced from the plant of claim 2, wherein said cells of the tissue culture are produced from a plant part selected from the group consisting of leaf, pollen, embryo, cotyledon, hypocotyl, meristematic cell, root, root tip, pistil, anther, flower, stem, pod and petiole.
4. A protoplast produced from the plant of claim 2.
5. A protoplast produced from the tissue culture of claim 3.
6. A soybean plant regenerated from the tissue culture of claim 3, wherein the plant has all of the morphological and physiological characteristics of cultivar 4211676.
7. A method for producing an F1 hybrid soybean seed, wherein the method comprises crossing the plant of claim 2 with a different soybean plant and harvesting the resultant F1 hybrid soybean seed.
8. A hybrid soybean seed produced by the method of claim 7.
9. A hybrid soybean plant, or a part thereof, produced by growing said hybrid seed of claim 8.
10. A method of producing an herbicide resistant soybean plant, wherein the method comprises transforming the soybean plant of claim 2 with a transgene wherein the transgene confers resistance to an herbicide selected from the group consisting of imidazolinone, sulfonylurea, glyphosate, glufosinate, L-phosphinothricin, triazine and benzonitrile.
11. An herbicide resistant soybean plant produced by the method of claim 10.
12. A method of producing an insect resistant soybean plant, wherein the method comprises transforming the soybean plant of claim 2 with a transgene that confers insect resistance.
13. An insect resistant soybean plant produced by the method of claim 12.
14. The soybean plant of claim 13, wherein the transgene encodes a Bacillus thuringiensis endotoxin.
15. A method of producing a disease resistant soybean plant, wherein the method comprises transforming the soybean plant of claim 2 with a transgene that confers disease resistance.
16. A disease resistant soybean plant produced by the method of claim 15.
17. A method of producing a soybean plant with modified fatty acid metabolism or modified carbohydrate metabolism, wherein the method comprises transforming the soybean plant of claim 2 with a transgene encoding a protein selected from the group consisting of phytase, fructosyltransferase, levansucrase, \u03b1-amylase, invertase and starch branching enzyme or encoding an antisense of stearyl-ACP desaturase.
18. A soybean plant having modified fatty acid metabolism or modified carbohydrate metabolism produced by the method of claim 17.
19. A method of introducing a desired trait into soybean cultivar 4211676, wherein the method comprises:
a. crossing a 4211676 plant, wherein a representative sample of seed was deposited under ATCC Accession No. PTA-9114, with a plant of another soybean cultivar that comprises a desired trait to produce progeny plants wherein the desired trait is selected from the group consisting of male sterility, herbicide resistance, insect resistance, modified fatty acid metabolism, modified carbohydrate metabolism, modified seed yield, modified oil percent, modified protein percent, modified lodging resistance, modified shattering, modified iron-deficiency chlorosis and resistance to bacterial disease, fungal disease or viral disease;
(b) selecting one or more progeny plants that have the desired trait to produce selected progeny plants;
(c) crossing the selected progeny plants with the 4211676 plants to produce backcross progeny plants;
(d) selecting for backcross progeny plants that have the desired trait and all of the physiological and morphological characteristics of soybean cultivar 4211676 listed in Table 1; and
(e) repeating steps (c) and (d) three or more times in succession to produce selected fourth or higher backcross progeny plants that comprise the desired trait and all of the physiological and morphological characteristics of soybean cultivar 4211676 listed in Table 1.
20. A soybean plant produced by the method of claim 19, wherein the plant has the desired trait and all of the physiological and morphological characteristics of soybean cultivar 4211676 listed in Table 1.
21. The soybean plant of claim 20, wherein the desired trait is herbicide resistance and the resistance is conferred to an herbicide selected from the group consisting of imidazolinone, sulfonylurea, glyphosate, glufosinate, L-phosphinothricin, triazine and benzonitrile.
22. The soybean plant of claim 20, wherein the desired trait is insect resistance and the insect resistance is conferred by a transgene encoding a Bacillus thuringiensis endotoxin.
23. The soybean plant of claim 20, wherein the desired trait is modified fatty acid metabolism or modified carbohydrate metabolism and said desired trait is conferred by a nucleic acid encoding a protein selected from the group consisting of phytase, fructosyltransferase, levansucrase, \u03b1-amylase, invertase and starch branching enzyme or encoding an antisense of stearyl-ACP desaturase.